A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

by Dennis Morrison, Thomas J. Legg, Christopher W. Billings, Remi Forrat, Sutee Yoksan, Jean Lang
Published 2018

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults

by Scott Kitchener, Michael Nissen, Peter Nasveld, Remi Forrat, Sutee Yoksan, Jean Lang, Jean François Saluzzo
Published 2018

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

by Arunee Sabchareon, Jean Lang, Pornthep Chanthavanich, Sutee Yoksan, Remi Forrat, Phanorsi Attanath, Chukiate Sirivichayakul, Krisana Pengsaa, Chanathep Pojjaroen-Anant, Laurent Chambonneau, Jean Francois Saluzzo, Natth Bhamarapravati
Published 2018

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™- DEN2) vaccine: Phase I clinical trial for safety and immunogenicity - Effect of yellow fever pre-immunity in induc...

by Farshad Guirakhoo, Scott Kitckener, Dennis Morrison, Remi Forrat, Karen McCarthy, Richard Nichols, Sutee Yoksan, Xiaochu Duan, Thomas H. Ermak, Niranjan Kanesa-Thasan, Philip Bedford, Jean Lang, Marie Jose Quentin-Millet, Thomas P. Monath
Published 2018